ENT manifestations of Sjogren’s syndrome: A narrative review
Keywords:
Sjogren’s syndrome, ENT manifestations, Autoimmune disease, Systemic lupus erythematosus, Systemic sclerosisAbstract
Sjogren's syndrome (SS) is an autoimmune condition marked by dryness of the mouth and eyes, frequently manifesting as a range of ENT symptoms that have a major negative impact on the quality of life of patients. Dryness and discomfort in the mouth and eyes, brought on by lacrimal and salivary gland dysfunction are ENT symptoms in SS. However, ENT regions are involved in more areas than just the ocular surface and mouth cavity. Due to laryngopharyngeal involvement, patients may experience hoarseness, dysphagia, and the sensation that something foreign is in their throat. Common nasal symptoms include nasal dryness, congestion, and recurrent sinusitis, while Eustachian tube dysfunction can lead to middle ear infections and hearing problems. To improve the quality of life in SS patients, clinicians and healthcare professionals should be careful in identifying and treating these symptoms. More investigations and clinical trials are required to create tailored medicines that can reduce ENT symptoms and enhance long-term outcomes for SS patients.
References
Ramos-Casals M, Tzioufas AG, Font J. Primary Sjogren’s syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005; 64: 347-54.
Eckhard A, Gleiser C, Arnold H, Rask-Andersen H, Kumagami H et al. Water channel proteins in the inner ear and their link to hearing impairment and deafness. Molecular Aspects of Medicine 2012; 33 (5-6): 612-637.
González JLT, Torres JR, Ríos YH, González MJV, MendezSaenz MA et al. Extended high-frequency audiometry as early detection of hearing loss in primary Sjögren syndrome. Clinical Rheumatology 2017; 36 (10): 2237-2241.
Calzada AP, Balaker AE, Ishiyama G, Lopez IA, Ishiyama A. Temporal bone histopathology and immunoglobulin deposition in Sjogren’s syndrome. OtolNeurotol 2012; 33: 258-66.
Tumiati B, Casoli P, Parmeggiani A. Hearing loss in the Sjogren syndrome. Ann Intern Med 1997; 126: 450-3.
Boki KA, Ioannidis JP, Segas JV, et al. How significant is sensorineural hearing loss in primary Sjögren’s syndrome? An individually matched case-control study. J Rheumatol 28: 28(4); 798-801.
Ziavra N, Politi EN, Kastanioudakis I, Skevas ADA. Hearing loss in Sjogren’s syndrome patients. A comparative study. ClinExpRheumatol 2000; 18: 725-8.
Almeida RS, Oliveira AA, Pego PM, Abuowda Y, Gaspar I, Costa JM. Sensorineural hearing loss as the first manifestation of Sjögren's syndrome. Revista da AssociaçãoMédicaBrasileira. 2017;63:7-9.
Jeong J, Lim H, Lee K, Hong CE, Choi HS. High Risk of Sudden Sensorineural Hearing Loss in Several Autoimmune Diseases according to a Population-Based National Sample Cohort Study. Audiol Neurootol. 2019;24(5):224-230
Rodríguez A, Roldán A, Villarreal IM et al (2016) Extended highfrequency audiometry (9,000–20,000 Hz). Usefulness in audiological diagnosis. ActaOtorrinolaringolEsp 67(1):40–44.
Houshang A, Jalil S, Hossein M et al (2014) Conventional audiometry, extended high-frequency audiometry, and DPOAE for early diagnosis of NIHL. Iran Red Cres Med J 16:1–6
Hwang JC, Gill AS, Squires LD, Steele TO. Sjögren’s Syndrome Sequelae: Nasal Synechiae and Nasopharyngeal Stenosis. Ear, Nose & Throat Journal. June 2020.
McCaffrey TV. Nasal manifestations of systemic diseases. Otolaryngol Pol. 2009;63(3):228-235.
Eren E, Balcı K, Gerçik Ö, Kabadayı G, Akar S. Does Nasal Secretion Decrease in Sjögren Syndrome and Does This Affect Nasal Function? Laryngoscope. 2021 Feb;131(2):370-373.
Liang Y, Yang Z, Qin B, Zhong R. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis. 2014 Jun;73(6):1151-6
Kamel UF, Maddison P, Whitaker R. Impact of primary Sjogren's syndrome on smell and taste: effect on quality of life. Rheumatology (Oxford). 2009 Dec;48(12):1512-4.
Midilli R, Gode S, Oder G, Kabasakal Y, Karci B. Nasal and paranasal involvement in primary Sjogren`s syndrome. Rhinology. 2013 Sep;51(3):265-7.
Mathews SA, Kurien BT. Critical reviews in oral biology & medicine oral manifestations of Sjögren’s Syndrome. Crit Rev Oral Biol Med 2007: 308-18.
Marton K, Boros I, Varga G, et al. Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjogren’s syndrome. Oral Dis 2006; 12: 480-6.
Madani G, Beale T. Inflammatory conditions of the salivary glands. Semin Ultrasound CT MR. 2006 Dec;27(6):440-51
Hong J, Zhu W, Zhuang H, et al. In vivo confocal microscopy of conjunctival goblet cells in patients with Sjogren’s syndrome dry eye. Br J Ophthalmol 2010; 94: 1454-8.
Tucci M, Quatraro C, Silvestris F. Sjogren’s syndrome: an autoimmune disorder with otolaryngological involvement. ActaOtorhinolaryngol Ital OrganoUff Della Soc Ital Di Otorinolaringol E ChirCervico-Facciale 2005; 25: 139-44.
Edelstein R, Kilipiris GE, Machalekova K, Mouzalini E, Slobodianuk A, Javorka V. Accuracy of minor salivary gland biopsy in the diagnosis of Sjögren syndrome. BratislLekListy. 2021;122(7):454- 460.
Guo Y, Sun N, Wu C, Xue L, Zhou Q. Sialendoscopy-assisted treatment for chronic obstructive parotitis related to Sjogren syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol 2016: 123(3): 1-5.
Izumi M, Eguchi K, Nakamura H, et al: Premature fat deposition in the salivary glands associated with Sjogren syndrome: MR and CT evidence. AJNR Am J Neuroradiol 18:951-958, 1
Toh AS, Broomfield SJ, Teh LS, Aslam MB, Duncan G, Morar P. Bilateral multicystic parotid masses in primary Sjögren syndrome. Ear, Nose & Throat Journal. 2011 Oct;90(10):E20-2.
Hsu S, Dickinson D. A new approach to managing oral manifestations of Sjogren’s syndrome and skin manifestations of lupus. J BiochemMolBiol 2006; 39: 229-39.
Billings RJ, Proskin HM, Moss ME. Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol 1996; 24: 312-6.
Generali E, Costanzo A, Mainetti C, Selmi C. Cutaneous and mucosal manifestations of Sjögren’s syndrome. Clinical reviews in allergy & immunology. 2017 Dec;53(3):357-70.
Kamiński B. Laryngological manifestations of Sjögren's syndrome. Reumatologia. 2019;57(1):37-44.
Pierce JL, Tanner K, Merrill RM, Miller KL, Ambati BK, Kendall KA, Roy N. Voice disorders in S jögren's syndrome: Prevalence and related risk factors. The Laryngoscope. 2015 Jun;125(6):1385-92.
Saltürk Z, Özdemir E, Kumral TL, Karabacakoğlu Z, Kumral E, Yildiz HE, Mersinlioğlu G, Atar Y, Berkiten G, Yildirim G, Uyar Y. Subjective and objective voice evaluation in Sjögren’s syndrome. LogopedicsPhoniatricsVocology. 2017 Jan 2;42(1):9-11.
Ruiz Allec LD, Herna´ndezLo´pez X, Arreguı´n Porras JB, Velasco Ramos R, Pacheco del Valle JC, Pe´rezGarcı´a AI. [Alterations in voice, speech, and swallowing in patients with Sjo¨gren’s syndrome]. ActaOtorrinolaringol Esp. 2011;62:255–64.
Heller A, Tanner K, Roy N, Nissen SL, Merrill RM, Miller KL, et al. Voice, speech, and laryngeal features of primary Sjo¨gren’s syndrome. Ann OtolRhinolLaryngol. 2014;123:778–85.
Ogut F, Midilli R, Oder G, Engin EZ, Karci B, Kabasakal Y. Laryngeal findings and voice quality in Sjo¨gren’s syndrome. Auris Nasus Larynx. 2005;32:375–80.
Korst RJ. Primary lymphoma of the subglottic airway in a patient with Sjogren’s syndrome mimicking high laryngotracheal stenosis. The Annals of thoracic surgery. 2007 Nov 1;84(5):1756-8.
YıldızerKeris E, Yaman SD, Demirağ MD, Haznedaroğlu Ş. Temporomandibular joint findings in patients with rheumatoid arthritis, ankylosing spondylitis, and primary Sjögren's syndrome. Journal of investigative and clinical dentistry. 2017 Nov;8(4):e12255.
Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A. A longitudinal cohort study of Finnish patients with primary Sjogren’s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis. 2001;60:467–472.
Crincoli V, Fatone L, Fanelli M, Rotolo RP, Chialà A, Favia G, Lapadula G. Orofacial manifestations and temporomandibular disorders of systemic scleroderma: an observational study. International journal of molecular sciences. 2016 Jul;17(7):1189.
Weiffenbach JM, Fox PC, Baum BJ, Burghauser R. Taste and salivary function. Proc Natl AcadSci USA 1986;83:6103–6.
Negoro A, Umemoto M, Fujii M, Kakibuchi M, Terada T, Hashimoto N, Sakagami M. Taste function in Sjögren’s syndrome patients with special reference to clinical tests. Auris Nasus Larynx. 2004 Jun 1;31(2):141-7.
Henkin RI, Talal N, Larson AL, Mattern CF. Abnormalities of taste and smell in Sjögren’s syndrome. Ann Intern Med 1972;76:375–83.
Weiffenbach JM, Schwartz LK, Atkinson JC, Fox PC. Taste performance in Sjögren’s syndrome. PhysiolBehav 1995;57:89–96.
Amos J, Baron A, Rubin AD. Autoimmune swallowing disorders. Curr Opin Otolaryngol Head Neck Surg. 2016 Dec;24(6):483-488.
Pierce JL, Tanner K, Merrill RM, et al. Swallowing disorders in Sjogren’s syndrome: prevalence, risk factors, and effects on quality of life. Dysphagia 2016; 31:49–59.
Eyigör S, Sezgin B, Karabulut G, Öztürk K, Göde S, Kirazlı T. Evaluation of swallowing functions in patients with Sjögren’s syndrome. Dysphagia. 2017 Apr 1;32(2):271-8.
Mandl T, Ekberg O, Wollmer P, Manthorpe R, Jacobsson LT. Dysphagia and dysmotility of the pharynx and esophagus in patients with primary Sjögren's syndrome. Scandinavian journal of rheumatology. 2007 Jan 1;36(5):394-401.
